NEWS

Curio Biotech : A start-up in Visp makes animal testing redundant

The young company Curio Biotech uses human tissue to test cosmetic products and medicines. Thanks to its innovative working method, the company is helping to reduce the number of animal experiments. The company’s founder, Chennakesava Cuddapah, sees great potential in Curio Biotech’s field of activity. In this interview, he gives us a look behind the …

Curio Biotech : A start-up in Visp makes animal testing redundant Read More »

DePoly Breaks Ground on Its First Revolutionary Plastic Recycling Plant in Monthey

Swiss CleanTech startup DePoly, supported by The Ark Foundation, has begun construction of its groundbreaking Showcase Plant in Monthey, marking a significant milestone in sustainable plastic recycling and reinforcing the region’s position as a hub for innovative technologies. A Leap Forward in Plastic Recycling DePoly’s new facility, located at the CIMO site in Monthey, will …

DePoly Breaks Ground on Its First Revolutionary Plastic Recycling Plant in Monthey Read More »

Orio Therapeutics on Radio Chablais

Discover the interview of Ziad Julier, co-founder of start-up Orio Therapeutics, based at the BioArk in Monthey, on Radio Chablais. Ziad presents their new cardio-protective drug technology, currently in the development phase, and his entrepreneurial journey. > Listen here “Our ultimate goal is for an acute patient who has had a heart attack to be …

Orio Therapeutics on Radio Chablais Read More »

An international delegation discovers BioArk in Monthey

A delegation of around fifty international life sciences specialists visited BioArk in Monthey on 24 April. It was an opportunity to get to know the Valais ecosystem in this field, with presentations by Valais start-ups and a conference by the Idiap research institute on artificial intelligence. The visit to the Valais was organised as part of Swiss Biotech Day, one of the biggest life sciences events in Switzerland.

BioArk invites you to take part in the online event Biotechgate Digital Partnering

Biotechgate Digital Partnering is an online event that runs four times a year to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Biotechgate Digital Partnering usually hosts over 1,000 representatives from leading life science companies and investors from around the globe, including big pharma, biotech start-ups and corporate investors.
The next edition of the popular five-day international conference series will be held virtually from May 13 to 17, 2024, and is free to attend.

The HES-SO Valais-Wallis strengthens its national positioning in Life Sciences

The HES-SO Valais-Wallis School of Engineering is today unveiling a major change in the way it promotes its educational offerings and research and innovation skills in the life sciences sector.
Over the past few years, the Swiss biopharmaceutical and food industries have undergone a rapid shift towards life sciences. Driven by innovation, collaboration and a commitment to health, wellbeing and sustainability, a number of partner companies of the Swiss College of Engineering (HEI), such as Debiopharm and Lonza, have massively expanded these business areas to meet the needs of the economy.

2024: a promising year for biotech

In a recent article published in the Agefi, the year 2023 saw a rise in mergers and acquisitions in the biotech sector, despite a slowdown in IPOs. While 2024 promises to be an optimistic year, investors are urged to be cautious about the haste of start-ups to go public.

Scroll to Top